+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Tissue Diagnostic Market by Product Type, by Technology, in Situ Hybridization, Digital Pathology and Workflow Management, and Special Staining, by Diseases, and Others, and by End-users

  • ID: 4854173
  • Report
  • October 2018
  • Region: Global
  • 110 pages
  • Zion Market Research
1 of 2

Enquire about COVID-19 updates for this product.

Enquire Now

The report covers forecast and analysis for the tissue diagnostic market on a global and regional level. The study provides historic data for 2016 and 2017 along with a forecast from 2018 to 2026 based on revenue (USD Million). The study includes drivers and restraints for the tissue diagnostic market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the tissue diagnostic market on a global level.

In order to give the users of this report a comprehensive view of the tissue diagnostic market, we have included the competitive landscape and analysis of Porter’s Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein all the segments are benchmarked based on their market size, growth rate, and general attractiveness.

The report provides company market share analysis in order to give a broader overview of the key players, in the market. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new diseases launch, agreements, partnerships, collaborations & joint ventures, research & development, Diseases and regional expansion of major participants involved in the market on the global and regional basis. Moreover, the study covers price trend analysis, applications portfolio of various companies according to the region.

The study provides a decisive view of the tissue diagnostic market by segmenting the market based on product type, technology, diseases, end-users, and regions. All the segments have been analyzed based on present and the future trends and the market is estimated from 2018 to 2026. By product type, the market is segmented into consumables and instruments. The consumables segment is further classified into kits & reagents and probes. The instruments segment is sub-segmented into slide-staining systems, scanners, tissue-processing systems, and others. Based on diseases the global tissue diagnostic market is segmented into immunohistochemistry (IHC), in situ hybridization (ISH), Digital pathology and workflow management, and special staining. Technology segment in global tissue diagnostic market is bifurcated into breast cancer, gastric cancer, lymphoma, prostate cancer, non-small cell lung cancer (NSCLC), and others. Hospitals, research laboratories, ambulatory surgical centers, diagnostic centers, and others are the key end-user segment of the global tissue diagnostic market.

The regional segmentation includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa with its further segmented into major countries including the U.S., Rest of North America, the U.K., Germany, France, Italy, Spain, Rest of Europe, China, Japan, India, southeast Asia, Rest of Asia Pacific, Brazil, Rest of Latin America, GCC Countries, South Africa and Rest of Middle East and Africa. This segmentation includes demand for tissue diagnostic market based on individual product, technology, diseases, and end-users in all the regions and countries.

The report also includes detailed profiles of end players such as Roche Diagnostic, Agilent Technologies, Danaher Corp., Genomic Health Inc., 3DHISTECH, Abbott Laboratories, GE Healthcare, Becton Dickinson & Co., Cell Signaling Technologies, Thermo Fisher Scientific Inc. among others.

This report segments the global tissue diagnostic market as follows:

Global Tissue Diagnostic Market: Product Type Segment Analysis

  • Consumables
  • Kits & Reagents
  • Probes
  • Instruments 
  • Slide-Staining Systems
  • Scanners
  • Tissue-Processing Systems
  • Other 

Global Tissue Diagnostic Market: Diseases Segment Analysis

  • Immunohistochemistry (IHC) 
  • in Situ Hybridization (ISH) 
  • Digital Pathology and Workflow Management
  • Special Staining

Global Tissue Diagnostic Market: Technology Segment Analysis

  • Breast Cancer 
  • Gastric Cancer 
  • Lymphoma 
  • Prostate Cancer
  • Non-Small Cell Lung Cancer (NSCLC)
  • Others

Global Tissue Diagnostic Market: End-user Segment Analysis

  • Hospitals
  • Research Laboratories
  • Ambulatory Surgical Centers
  • Diagnostic Centers
  • Others

Global Tissue Diagnostic Market: Regional Segment Analysis

  • North America
  • The U.S.
  • Europe
  • UK
  • France
  • Germany
  • Asia Pacific
  • China
  • Japan
  • India
  • Latin America
  • Brazil
  • Middle East and Africa
Note: Product cover images may vary from those shown
2 of 2
  • Chapter 1. Introduction
    • 1.1. Report description and scope
    • 1.2. Research scope
    • 1.3. Research methodology
      • 1.3.1. Market research process
      • 1.3.2. Market research methodology
  • Chapter 2. Executive Summary
    • 2.1. Global Tissue Diagnostic Market, 2017 - 2026(USD Million)
    • 2.2. Global Tissue Diagnostic Market: snapshot
  • Chapter 3. Tissue Diagnostic Market- Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Global Tissue Diagnostic Market drivers: impact analysis
      • 3.2.2. Technological Advancements
      • 3.2.3. Rising Patient Prominence on Early and Effective Disease Diagnosis
      • 3.2.4. Increasing incidence of cancer
      • 3.2.5. Improving technologies for cancer diagnostics
      • 3.2.6. Rapid increase in aging population
    • 3.3. Market Restraints
      • 3.3.1. Global Tissue Diagnostic Market restraints: impact analysis
      • 3.3.2. High cost of treatment
    • 3.4. Opportunities
      • 3.4.1. Emerging Markets
      • 3.4.2. Rising Market Preference for Early Diagnostics of Targeted Technology
      • 3.4.3. Ongoing Market Shift Towards Improved and Effective Diagnostic Techniques
    • 3.5. Porter's five forces analysis
      • 3.5.1. Bargaining power of suppliers
      • 3.5.2. Bargaining power of buyers
      • 3.5.3. Threat from new entrants
      • 3.5.4. Threat from new substitutes
      • 3.5.5. Degree of competition
    • 3.6. Market Attractiveness Analysis
      • 3.6.1. Market attractiveness analysis, by product type segment
      • 3.6.2. Market attractiveness analysis, by Technology segment
      • 3.6.3. Market attractiveness analysis, by Diseases segment
      • 3.6.4. Market attractiveness analysis, by end user segment
      • 3.6.5. Market attractiveness analysis, by regional segment
  • Chapter 4. Global Tissue Diagnostic Market- Competitive Landscape
    • 4.1. Company market share analysis
      • 4.1.1. Global Tissue Diagnostic Market: company market share, 2017
    • 4.2. Strategic development
      • 4.2.1. Acquisitions & mergers
      • 4.2.2. New therapy launch
      • 4.2.3. Agreements, partnerships, collaborations and joint ventures
      • 4.2.4. Research and development and regional expansion
  • Chapter 5. Global Tissue Diagnostic Market- Product Type Segment Analysis
    • 5.1. Global Tissue Diagnostic Market: product overview
      • 5.1.1. Global Tissue Diagnostic Market revenue share, by product type, 2017 and 2026
    • 5.2. Consumables
      • 5.2.1. Global Tissue Diagnostic Market for Consumables, 2017 - 2026(USD Million)
      • 5.2.2. Global Tissue Diagnostic Market for Kits & Reagents, 2017 - 2026(USD Million)
      • 5.2.3. Global Tissue Diagnostic Market for Probes, 2017 - 2026(USD Million)
    • 5.3. Instruments
      • 5.3.1. Global Tissue Diagnostic Market for Instruments, 2017 - 2026 (USD Million)
      • 5.3.2. Global Tissue Diagnostic Market for Slide-Staining Systems, 2017 - 2026 (USD Million)
      • 5.3.3. Global Tissue Diagnostic Market for Scanners, 2017 - 2026 (USD Million)
      • 5.3.4. Global Tissue Diagnostic Market for Tissue-Processing Systems, 2017 - 2026 (USD Million)
      • 5.3.5. Global Tissue Diagnostic Market for Other Instruments, 2017 - 2026 (USD Million)
  • Chapter 6. Global Tissue Diagnostic Market- Technology Segment Analysis
    • 6.1. Global Tissue Diagnostic Market: Technology type overview
      • 6.1.1. Global Tissue Diagnostic Market revenue share, by Technology, 2017 and 2026
    • 6.2. Immunohistochemistry (IHC)
      • 6.2.1. Global Tissue Diagnostic Market for Immunohistochemistry (IHC), 2017 - 2026 (USD Million)
    • 6.3. in Situ Hybridization (ISH)
      • 6.3.1. Global Tissue Diagnostic Market for in Situ Hybridization (ISH), 2017 - 2026 (USD Million)
    • 6.4. Digital Pathology and Workflow Management
      • 6.4.1. Global Tissue Diagnostic Market for Digital Pathology and Workflow Management, 2017 - 2026 (USD Million)
    • 6.5. Special Staining
      • 6.5.1. Global Tissue Diagnostic Market for Special Staining, 2017 - 2026 (USD Million)
  • Chapter 7. Global Tissue Diagnostic Market- Diseases Segment Analysis
    • 7.1. Global Tissue Diagnostic Market: Diseases type overview
      • 7.1.1. Global Tissue Diagnostic Market revenue share, by Diseases, 2017 and 2026
    • 7.2. Breast Cancer
      • 7.2.1. Global Tissue Diagnostic Market for Breast Cancer, 2017 - 2026 (USD Million)
    • 7.3. Gastric Cancer
      • 7.3.1. Global Tissue Diagnostic Market for Gastric Cancer, 2017 - 2026 (USD Million)
    • 7.4. Lymphoma
      • 7.4.1. Global Tissue Diagnostic Market for Lymphoma,2017 - 2026(USD Million)
    • 7.5. Prostate Cancer
      • 7.5.1. Global Tissue Diagnostic Market for Prostate Cancer,2017 - 2026(USD Million)
    • 7.6. Non-Small Cell Lung Cancer (NSCLC)
      • 7.6.1. Global Tissue Diagnostic Market for Non-Small Cell Lung Cancer (NSCLC), 2017 - 2026(USD Million)
    • 7.7. Other
      • 7.7.1. Global Tissue Diagnostic Market for Other, 2017 - 2026(USD Million)
  • Chapter 8. Global Tissue Diagnostic Market- End-User Segment Analysis
    • 8.1. Global Tissue Diagnostic Market: End User type overview
      • 8.1.1. Global Tissue Diagnostic Market revenue share, by End User, 2017 and 2026
    • 8.2. Hospitals
      • 8.2.1. Global Tissue Diagnostic Market for Hospitals, 2017 - 2026 (USD Million)
    • 8.3. Research Laboratories
      • 8.3.1. Global Tissue Diagnostic Market for Research Laboratories, 2017 - 2026 (USD Million)
    • 8.4. Ambulatory Surgical Centers
      • 8.4.1. Global Tissue Diagnostic Market for Ambulatory Surgical Centers, 2017 - 2026(USD Million)
    • 8.5. Diagnostic Centers
      • 8.5.1. Global Tissue Diagnostic Market for Diagnostic Centers, 2017 - 2026(USD Million)
    • 8.6. Others
      • 8.6.1. Global Tissue Diagnostic Market for other end user,2017 - 2026(USD Million)
  • Chapter 9. Global Tissue Diagnostic Market- Regional Segment Analysis
    • 9.1. Global Tissue Diagnostic Market: regional overview
      • 9.1.1. Global Tissue Diagnostic Market revenue share, by region, 2017 and 2026
    • 9.2. North America
      • 9.2.1. North America Tissue Diagnostic Market revenue, by Product type, 2017 - 2026(USD Million)
      • 9.2.2. North America Tissue Diagnostic Market revenue, by Technology, 2017 - 2026(USD Million)
      • 9.2.3. North America Tissue Diagnostic Market revenue, by Diseases, 2017 - 2026(USD Million)
      • 9.2.4. North America Tissue Diagnostic Market revenue, by End User, 2017 - 2026(USD Million)
      • 9.2.5. U.S.
        • 9.2.5.1. U.S. Tissue Diagnostic Market revenue, by product type, 2017 - 2026(USD Million)
        • 9.2.5.2. U.S. Tissue Diagnostic Market revenue, by Technology, 2017 - 2026(USD Million)
        • 9.2.5.3. U.S. Tissue Diagnostic Market revenue, by Diseases, 2017 - 2026(USD Million)
        • 9.2.5.4. U.S. Tissue Diagnostic Market revenue, by End User, 2017 - 2026(USD Million)
      • 9.2.6. Rest of North America
        • 9.2.6.1. Rest of North America Tissue Diagnostic Market revenue, by Product type, 2017 - 2026(USD Million)
        • 9.2.6.2. Rest of North America Tissue Diagnostic Market revenue, by Technology, 2017 - 2026(USD Million)
        • 9.2.6.3. Rest of North America Tissue Diagnostic Market revenue, by Diseases, 2017 - 2026(USD Million)
        • 9.2.6.4. Rest of North America Tissue Diagnostic Market revenue, by End User, 2017 - 2026(USD Million)
    • 9.3. Europe
      • 9.3.1. Europe Tissue Diagnostic Market revenue, by Product type, 2017 - 2026(USD Million)
      • 9.3.2. Europe Tissue Diagnostic Market revenue, by Technology, 2017 - 2026(USD Million)
      • 9.3.3. Europe Tissue Diagnostic Market revenue, by Diseases, 2017 - 2026(USD Million)
      • 9.3.4. Europe Tissue Diagnostic Market revenue, by End User, 2017 - 2026(USD Million)
      • 9.3.5. U.K.
        • 9.3.5.1. U.K. Tissue Diagnostic Market revenue, by Product type, 2017 - 2026 (USD Million)
        • 9.3.5.2. U.K. Tissue Diagnostic Market revenue, by Technology, 2017 - 2026 (USD Million)
        • 9.3.5.3. U.K. Tissue Diagnostic Market revenue, by Diseases, 2017 - 2026(USD Million)
        • 9.3.5.4. U.K. Tissue Diagnostic Market revenue, by End User, 2017 - 2026(USD Million)
      • 9.3.6. Germany
        • 9.3.6.1. Germany Tissue Diagnostic Market revenue, by Product type, 2017 - 2026(USD Million)
        • 9.3.6.2. Germany Tissue Diagnostic Market revenue, by Technology, 2017 - 2026(USD Million)
        • 9.3.6.3. Germany Tissue Diagnostic Market revenue, by Diseases, 2017 - 2026(USD Million)
        • 9.3.6.4. Germany Tissue Diagnostic Market revenue, by End User, 2017 - 2026(USD Million)
      • 9.3.7. France
        • 9.3.7.1. France Tissue Diagnostic Market revenue, by Product type, 2017 - 2026(USD Million)
        • 9.3.7.2. France Tissue Diagnostic Market revenue, by Technology, 2017 - 2026(USD Million)
        • 9.3.7.3. France Tissue Diagnostic Market revenue, by Diseases, 2017 - 2026(USD Million)
        • 9.3.7.4. France Tissue Diagnostic Market revenue, by End User, 2017 - 2026(USD Million)
      • 9.3.8. Italy
        • 9.3.8.1. Italy Tissue Diagnostic Market revenue, by Product type, 2017 - 2026(USD Million)
        • 9.3.8.2. Italy Tissue Diagnostic Market revenue, by Technology, 2017 - 2026(USD Million)
        • 9.3.8.3. Italy Tissue Diagnostic Market revenue, by Diseases, 2017 - 2026(USD Million)
        • 9.3.8.4. Italy Tissue Diagnostic Market revenue, by End User, 2017 - 2026(USD Million)
      • 9.3.9. Spain
        • 9.3.9.1. Spain Tissue Diagnostic Market revenue, by Product type, 2017 - 2026(USD Million)
        • 9.3.9.2. Spain Tissue Diagnostic Market revenue, by Technology, 2017 - 2026(USD Million)
        • 9.3.9.3. Spain Tissue Diagnostic Market revenue, by Diseases, 2017 - 2026(USD Million)
        • 9.3.9.4. Spain Tissue Diagnostic Market revenue, by End User, 2017 - 2026(USD Million)
      • 9.3.10. Rest of Europe
        • 9.3.10.1. Rest of Europe Tissue Diagnostic Market revenue, by Product type, 2017 - 2026(USD Million)
        • 9.3.10.2. Rest of Europe Tissue Diagnostic Market revenue, by Technology, 2017 - 2026(USD Million)
        • 9.3.10.3. Rest of Europe Tissue Diagnostic Market revenue, by Diseases, 2017 - 2026(USD Million)
        • 9.3.10.4. Rest of Europe Tissue Diagnostic Market revenue, by End User, 2017 - 2026(USD Million)
    • 9.4. Asia Pacific
      • 9.4.1. Asia Pacific Tissue Diagnostic Market revenue, by Product type, 2017 - 2026 (USD Million)
      • 9.4.2. Asia Pacific Tissue Diagnostic Market revenue, by Technology, 2017 - 2026(USD Million)
      • 9.4.3. Asia Pacific Tissue Diagnostic Market revenue, by Diseases, 2017 - 2026(USD Million)
      • 9.4.4. Asia Pacific Tissue Diagnostic Market revenue, by End User, 2017 - 2026(USD Million)
      • 9.4.5. China
        • 9.4.5.1. China Tissue Diagnostic Market revenue, by Product type, 2017 - 2026(USD Million)
        • 9.4.5.2. China Tissue Diagnostic Market revenue, by Technology, 2017 - 2026(USD Million)
        • 9.4.5.3. China Tissue Diagnostic Market revenue, by Diseases, 2017 - 2026(USD Million)
        • 9.4.5.4. China Tissue Diagnostic Market revenue, by End User, 2017 - 2026(USD Million)
      • 9.4.6. Japan
        • 9.4.6.1. Japan Tissue Diagnostic Market revenue, by Product type, 2017 - 2026(USD Million)
        • 9.4.6.2. Japan Tissue Diagnostic Market revenue, by Technology, 2017 - 2026(USD Million)
        • 9.4.6.3. Japan Tissue Diagnostic Market revenue, by Diseases, 2017 - 2026(USD Million)
        • 9.4.6.4. Japan Tissue Diagnostic Market revenue, by End User, 2017 - 2026(USD Million)
      • 9.4.7. India
        • 9.4.7.1. India Tissue Diagnostic Market revenue, by Product type, 2017 - 2026(USD Million)
        • 9.4.7.2. India Tissue Diagnostic Market revenue, by Technology, 2017 - 2026(USD Million)
        • 9.4.7.3. India Tissue Diagnostic Market revenue, by Diseases, 2017 - 2026(USD Million)
        • 9.4.7.4. India Tissue Diagnostic Market revenue, by End User, 2017 - 2026(USD Million)
      • 9.4.8. Southeast Asia
        • 9.4.8.1. Southeast Asia Tissue Diagnostic Market revenue, by Product type, 2017 - 2026(USD Million)
        • 9.4.8.2. Southeast Asia Tissue Diagnostic Market revenue, by Technology, 2017 - 2026(USD Million)
        • 9.4.8.3. Southeast Asia Tissue Diagnostic Market revenue, by Diseases, 2017 - 2026(USD Million)
        • 9.4.8.4. Southeast Asia Tissue Diagnostic Market revenue, by End User, 2017 - 2026(USD Million)
      • 9.4.9. Rest of Asia Pacific
        • 9.4.9.1. Rest of Asia Pacific Tissue Diagnostic Market revenue, by Product type, 2017 - 2026(USD Million)
        • 9.4.9.2. Rest of Asia Pacific Tissue Diagnostic Market revenue, by Technology, 2017 - 2026(USD Million)
        • 9.4.9.3. Rest of Asia Pacific Tissue Diagnostic Market revenue, by Diseases, 2017 - 2026(USD Million)
        • 9.4.9.4. Rest of Asia Pacific Tissue Diagnostic Market revenue, by End User, 2017 - 2026(USD Million)
    • 9.5. Latin America
      • 9.5.1. Latin America Tissue Diagnostic Market revenue, by Product type, 2017 - 2026(USD Million)
      • 9.5.2. Latin America Tissue Diagnostic Market revenue, by Technology, 2017 - 2026(USD Million)
      • 9.5.3. Latin America Tissue Diagnostic Market revenue, by Diseases, 2017 - 2026(USD Million)
      • 9.5.4. Latin America Tissue Diagnostic Market revenue, by end user, 2017 - 2026(USD Million)
      • 9.5.5. Brazil
        • 9.5.5.1. Brazil Tissue Diagnostic Market revenue, by Product type, 2017 - 2026(USD Million)
        • 9.5.5.2. Brazil Tissue Diagnostic Market revenue, by Technology, 2017 - 2026(USD Million)
        • 9.5.5.3. Brazil Tissue Diagnostic Market revenue, by Diseases, 2017 - 2026(USD Million)
        • 9.5.5.4. Brazil Tissue Diagnostic Market revenue, by End User, 2017 - 2026(USD Million)
      • 9.5.6. Rest of Latin America
        • 9.5.6.1. Rest of Latin America Tissue Diagnostic Market revenue, by Product type, 2017 - 2026(USD Million)
        • 9.5.6.2. Rest of Latin America Tissue Diagnostic Market revenue, by Technology, 2017 - 2026(USD Million)
        • 9.5.6.3. Rest of Latin America Tissue Diagnostic Market revenue, by Diseases, 2017 - 2026(USD Million)
        • 9.5.6.4. Rest of Latin America Tissue Diagnostic Market revenue, by End User, 2017 - 2026(USD Million)
    • 9.6. Middle East and Africa
      • 9.6.1. Middle East and Africa Tissue Diagnostic Market revenue, by Product type, 2017 - 2026(USD Million)
      • 9.6.2. Middle East and Africa Tissue Diagnostic Market revenue, by Technology, 2017 - 2026(USD Million)
      • 9.6.3. Middle East and Africa Tissue Diagnostic Market revenue, by Diseases, 2017 - 2026(USD Million)
      • 9.6.4. Middle East and Africa Tissue Diagnostic Market revenue, by end user, 2017 - 2026(USD Million)
      • 9.6.5. GCC Countries
        • 9.6.5.1. GCC Countries Tissue Diagnostic Market revenue, by Product type, 2017 - 2026(USD Million)
        • 9.6.5.2. GCC Countries Tissue Diagnostic Market revenue, by Technology, 2017 - 2026(USD Million)
        • 9.6.5.3. GCC Countries Tissue Diagnostic Market revenue, by Diseases, 2017 - 2026(USD Million)
        • 9.6.5.4. GCC Countries Tissue Diagnostic Market revenue, by End User, 2017 - 2026(USD Million)
      • 9.6.6. South Africa
        • 9.6.6.1. South Africa Tissue Diagnostic Market revenue, by Product type, 2017 - 2026(USD Million)
        • 9.6.6.2. South Africa Tissue Diagnostic Market revenue, by Technology, 2017 - 2026(USD Million)
        • 9.6.6.3. South Africa Tissue Diagnostic Market revenue, by Diseases, 2017 - 2026(USD Million)
        • 9.6.6.4. South Africa Tissue Diagnostic Market revenue, by End User, 2017 - 2026(USD Million)
      • 9.6.7. Rest of Middle East and Africa
        • 9.6.7.1. Rest of Middle East and Africa Tissue Diagnostic Market revenue, by Product type, 2017 - 2026(USD Million)
        • 9.6.7.2. Rest of Middle East and Africa Tissue Diagnostic Market revenue, by Technology, 2017 - 2026(USD Million)
        • 9.6.7.3. Rest of Middle East and Africa Tissue Diagnostic Market revenue, by Diseases, 2017 - 2026(USD Million)
        • 9.6.7.4. Rest of Middle East and Africa Tissue Diagnostic Market revenue, by End User, 2017 - 2026(USD Million)
  • Chapter 10. Company Profile
    • 10.1. Roche Diagnostic
      • 10.1.1. Overview
      • 10.1.2. Financials
      • 10.1.3. Product portfolio
      • 10.1.4. Business strategy
      • 10.1.5. Recent developments
    • 10.2. Agilent Technologies
      • 10.2.1. Overview
      • 10.2.2. Financials
      • 10.2.3. Product portfolio
      • 10.2.4. Business strategy
      • 10.2.5. Recent developments
    • 10.3. GE Healthcare
      • 10.3.1. Overview
      • 10.3.2. Financials
      • 10.3.3. Product portfolio
      • 10.3.4. Business strategy
      • 10.3.5. Recent developments
    • 10.4. Danaher Corp.
      • 10.4.1. Overview
      • 10.4.2. Financials
      • 10.4.3. Product portfolio
      • 10.4.4. Business strategy
    • 10.5. Genomic Health Inc.
      • 10.5.1. Overview
      • 10.5.2. Financials
      • 10.5.3. Product portfolio
      • 10.5.4. Business strategy
      • 10.5.5. Recent developments
    • 10.6. 3DHISTECH
      • 10.6.1. Overview
      • 10.6.2. Financials
      • 10.6.3. Product portfolio
      • 10.6.4. Business strategy
      • 10.6.5. Recent developments
    • 10.7. Abbott Laboratories
      • 10.7.1. Overview
      • 10.7.2. Financials
      • 10.7.3. Product portfolio
      • 10.7.4. Business strategy
      • 10.7.5. Recent developments
    • 10.8. Becton Dickinson & Co.
      • 10.8.1. Overview
      • 10.8.2. Financials
      • 10.8.3. Product portfolio
      • 10.8.4. Business strategy
      • 10.8.5. Recent developments
    • 10.9. Cell Signaling Technologies
      • 10.9.1. Overview
      • 10.9.2. Financials
      • 10.9.3. Product portfolio
      • 10.9.4. Business strategy
      • 10.9.5. Recent developments
    • 10.10. Thermo Fisher Scientific Inc.
      • 10.10.1. Overview
      • 10.10.2. Financials
      • 10.10.3. Product portfolio
      • 10.10.4. Business strategy
      • 10.10.5. Recent developments
Note: Product cover images may vary from those shown
Adroll
adroll